$0.68
Bionomics is a biotechnology business based in the US. Bionomics shares (BNOX) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top picks for where to buy Bionomics Ltd ADR stock
How to buy Bionomics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BNOX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Bionomics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Bionomics stock price (NASDAQ: BNOX)
Use our graph to track the performance of BNOX stocks over time.Bionomics shares at a glance
Latest market close | $0.67 |
---|---|
52-week range | $0.65 - $5.30 |
50-day moving average | $0.81 |
200-day moving average | $1.27 |
Wall St. target price | $6.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.06 |
Is it a good time to buy Bionomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bionomics price performance over time
Historical closes compared with the close of $0.6745 from 2024-07-25
1 week (2024-07-19) | -19.79% |
---|---|
1 month (2024-06-26) | -9.81% |
3 months (2024-04-26) | -32.55% |
6 months (2024-01-26) | -28.85% |
1 year (2023-07-26) | -66.94% |
---|---|
2 years (2022-07-26) | -91.08% |
3 years (2021-07-22) | N/A |
5 years (2019-07-22) | N/A |
Bionomics financials
Revenue TTM | $661,980 |
---|---|
Gross profit TTM | $-18,963,665 |
Return on assets TTM | -35.13% |
Return on equity TTM | -80.8% |
Profit margin | 0% |
Book value | $2.72 |
Market Capitalization | $11.1 million |
TTM: trailing 12 months
Bionomics share dividends
We're not expecting Bionomics to pay a dividend over the next 12 months.
You may also wish to consider:
- Merck-and-Company (MRK.US) (2.48% forward annual dividend yield)
- Johnson-and-Johnson (JNJ.US) (3.28% forward annual dividend yield)
- UnitedHealth Group Incorporated (UNH.US) (1.49% forward annual dividend yield)
Bionomics share price volatility
Over the last 12 months, Bionomics's shares have ranged in value from as little as $0.65 up to $5.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bionomics's is -0.112. This would suggest that Bionomics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Bionomics has bucked the trend.
To put Bionomics's beta into context you can compare it against those of similar companies.
- Merck-and-Company (MRK.US): 0.389
- Johnson-and-Johnson (JNJ.US): 0.517
- UnitedHealth Group Incorporated (UNH.US): 0.603
Bionomics overview
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co. , Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.
Frequently asked questions
What percentage of Bionomics is owned by insiders or institutions?Currently 55.912% of Bionomics shares are held by insiders and 17.905% by institutions. When does the fiscal year end for Bionomics?
Bionomics's fiscal year ends in June. Where is Bionomics based?
Bionomics's address is: 200 Greenhill Road, Eastwood, SA, Australia, 5063 What is Bionomics's ISIN number?
Bionomics's international securities identification number is: US09063M2052
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy Mainz Biomed stock (Mainz Biomed)
Steps to owning and managing MYNZ, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Owlet Baby Care stock (Owlet Baby Care)
Steps to owning and managing OWLT, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question